153 related articles for article (PubMed ID: 19333729)
1. ECA-immunogenicity of Proteus mirabilis strains.
Duda KA; Duda KT; Beczała A; Kasperkiewicz K; Radziejewska-Lebrecht J; Skurnik M
Arch Immunol Ther Exp (Warsz); 2009; 57(2):147-51. PubMed ID: 19333729
[TBL] [Abstract][Full Text] [Related]
2. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
[TBL] [Abstract][Full Text] [Related]
3. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
[TBL] [Abstract][Full Text] [Related]
4. Characterization of anti-ECA antibodies in rabbit antiserum against rough Yersinia enterocolitica O:3.
Rabsztyn K; Kasperkiewicz K; Duda KA; Li CM; Lukasik M; Radziejewska-Lebrecht J; Skurnik M
Biochemistry (Mosc); 2011 Jul; 76(7):832-9. PubMed ID: 21999545
[TBL] [Abstract][Full Text] [Related]
5. Serological characterization of the enterobacterial common antigen substitution of the lipopolysaccharide of Yersinia enterocolitica O : 3.
Noszczyńska M; Kasperkiewicz K; Duda KA; Podhorodecka J; Rabsztyn K; Gwizdała K; Świerzko AS; Radziejewska-Lebrecht J; Holst O; Skurnik M
Microbiology (Reading); 2015 Jan; 161(Pt 1):219-227. PubMed ID: 25406452
[TBL] [Abstract][Full Text] [Related]
6. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
[TBL] [Abstract][Full Text] [Related]
7. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
[TBL] [Abstract][Full Text] [Related]
8. Enterobacterial common antigen and O-specific polysaccharide coexist in the lipopolysaccharide of Yersinia enterocolitica serotype O:3.
Muszyński A; Rabsztyn K; Knapska K; Duda KA; Duda-Grychtoł K; Kasperkiewicz K; Radziejewska-Lebrecht J; Holst O; Skurnik M
Microbiology (Reading); 2013 Aug; 159(Pt 8):1782-1793. PubMed ID: 23782803
[TBL] [Abstract][Full Text] [Related]
9. The core region of Proteus mirabilis R110/1959 lipopolysaccharide.
Radziejewska-Lebrecht J; Mayer H
Eur J Biochem; 1989 Aug; 183(3):573-81. PubMed ID: 2673779
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide.
Peters H; Jürs M; Jann B; Jann K; Timmis KN; Bitter-Suermann D
Infect Immun; 1985 Nov; 50(2):459-66. PubMed ID: 2414223
[TBL] [Abstract][Full Text] [Related]
11. Antibodies Isolated from Rheumatoid Arthritis Patients against Lysine-Containing
Durlik-Popińska K; Żarnowiec P; Lechowicz Ł; Gawęda J; Kaca W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348817
[TBL] [Abstract][Full Text] [Related]
12. First evidence for a covalent linkage between enterobacterial common antigen and lipopolysaccharide in Shigella sonnei phase II ECALPS.
Gozdziewicz TK; Lugowski C; Lukasiewicz J
J Biol Chem; 2014 Jan; 289(5):2745-54. PubMed ID: 24324266
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serological reactions of Rickettsiae-infected patients and rabbit anti-Proteus OX antibodies with Proteus OX2, OX19 and OXK lipopolysaccharides.
Amano K; Cedzyński M; Swierzko AS; Kyohno K; Kaca W
Arch Immunol Ther Exp (Warsz); 1996; 44(4):235-40. PubMed ID: 9017163
[TBL] [Abstract][Full Text] [Related]
14. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype.
Rozalski A; Brade L; Kosma P; Appelmelk BJ; Krogmann C; Brade H
Infect Immun; 1989 Sep; 57(9):2645-52. PubMed ID: 2474499
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical studies on R mutants of Yersinia enterocolitica O:3.
Radziejewska-Lebrecht J; Skurnik M; Shashkov AS; Brade L; Rózalski A; Bartodziejska B; Mayer H
Acta Biochim Pol; 1998; 45(4):1011-9. PubMed ID: 10397347
[TBL] [Abstract][Full Text] [Related]
16. Immunological activities of purified preparations of enterobacterial common antigen.
Gannon PJ; Jacobs DM; Marx A; Mayer H; Romanowska E; Neter E
Infect Immun; 1982 Jan; 35(1):193-201. PubMed ID: 7033134
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-Linked Enterobacterial Common Antigen (ECA
Maciejewska A; Kaszowska M; Jachymek W; Lugowski C; Lukasiewicz J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839412
[TBL] [Abstract][Full Text] [Related]
18. The comparison of some biological activities of lipopolysaccharides obtained from smooth and rough Proteus mirabilis strains.
Klink M; Brzychcy M; Ziółkowski A; Swierzko A; Sułowska Z; Cedzyński M; Tchórzewski H
Acta Microbiol Pol; 1998; 47(2):141-51. PubMed ID: 9839373
[TBL] [Abstract][Full Text] [Related]
19. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
20. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis.
Arabski M; Fudala R; Koza A; Wasik S; Futoma-Koloch B; Bugla-Ploskonska G; Kaca W
Clin Biochem; 2012 Nov; 45(16-17):1374-82. PubMed ID: 22749779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
